Finally, we showed that immunoregulatory cytokines, which were strongly induced in monocytes in IFN-β-treated MS, interfered with the activation of antigen-specific CD4+ T-cells ex vivo, and demonstrated that monocytes had an immunoregulatory effect on MBP-reactive T cells. Here, IFNB1 is linked to myeloid sarcoma.